期刊文献+

间充质干细胞在肿瘤微环境中作用的研究进展 被引量:3

Research Progress of Mesenchymal Stem Cells in Tumor Microenvironment
原文传递
导出
摘要 干细胞的发现及其功能的研究是近年来医学乃至整个生命科学领域的研究热点。干细胞因其具有高度自我更新和多向分化潜能,是细胞移植的首选靶细胞。间充质干细胞具有较弱的免疫原性使其成为肿瘤生物治疗的首选载体,被广泛用于抗肿瘤的研究。但是,目前间充质干细胞和肿瘤细胞的相互关系已引起学者的关注,大量实验结果表明间充质干细胞和肿瘤的关系存在两面性,有研究证实干细胞能够抑制肿瘤细胞生长,但亦有研究表明干细胞能够促进肿瘤的生长和转移,甚或干细胞发生恶性转化,获得了肿瘤细胞的相关生物学特性。其临床应用的安全性和实用性也有待于进一步的验证。本文对骨髓间充质干细胞在肿瘤微环境中作用的研究进展作一简要综述。 The research of the discovery of stem cells and its function is the research hotspot in the medicine and the field of life science in recent years. Because of its high self-renewal and multi-directional differentiation potential,stem cells is the first choice for cell transplantation target cells. Mesenchymal stem cells with weak immunogenicity makes it a tumor biological treat-ment of choice for the carrier,is widely used in research of antitumor. But the current relationship between mesenchymal stem cells and tumor cells has aroused the attention of scholars. A large number of experimental results show that the existence of mesenchymal stem cells and tumor re-lations between two sides. Studies have confirmed that stem cells can inhibit the growth of tumor cells,but also studies have shown that stem cells can promote tumor growth and metastasis,or stem cells undergo malignant transformation,obtain the related biological characteristics of tumor cells. Safety and practicability of its clinical application are subject to further validation. In this paper,we review the research progress of the filling bone marrow stromal stem cells in the tumor microenvironment.
出处 《肿瘤学杂志》 CAS 2016年第6期501-505,共5页 Journal of Chinese Oncology
基金 甘肃省财政厅科研业务项目(BH-2013-23) 甘肃省中医管理局科研立项课题(GZK-2013-4)
关键词 间充质干细胞 肿瘤微环境 治疗 mesenchymal stem cells tumor microenvironment treatment
  • 相关文献

参考文献26

  • 1Xu W,Zhang X,Qian H,et al. Mesenchymal stem cells from adult human bone marrow differentiate into a car- diomyocyte phenotype in vitro[J]. Exp Biot Med, 2004,229 (7) : 623-631.
  • 2Hung SC,Deng WP,Yang WK,et al. Mesenehymal stem cell targeting of microcopic tumors and tumor stroma de- velopment monitored by noninvasive in vivo positron emis- sion tomography imaging[J]. Ctin Cancer Ges, 2005,11 (21) : 7749-7756.
  • 3Coffeh SB,Marini FC,Watson K,et al. The proinflammatoly peptide EL -37 promotes ovarian tumor progression through recruitment of muhipotent mesenchymal stromal cells [J]. Proc Natl Acad Sei U S A,2009,106(10) :3806-3811.
  • 4Lin G,Yang R, Banie L,et al. Effects of transplantation of adipose tissue-derived stem cells on prostate tumor [J]. Prostate, 2010,70(10) : 1066-1073.
  • 5Davatchi F,Abdollahi BS,Mohyeddin M,et al. Mesenchy- mal stem cell therapy for knee osteoarthritis.Preliminaryreport of four patients[J]. Int J Rheum Dis,2011,14(2): 211-215.
  • 6Cuiffo BG,Karnoub AE. Mesenchynmal stem cells in tu- mor development:emerging roles and concepts[J]. Cell Adh Migr, 2012,6(3) :220-230.
  • 7Dai LJ, Moniri MR,Zeng ZR,et al. Potential implications of mesenehymal stem cells in cancer therapy[J]. Cancer Lett, 2011,305(1) : 8-20.
  • 8Pauneseu V,Bojin FM,Tatu CA,et al. Tnmour-associated fibroblasts and mesenehymal stem cells :more similarities than differences [J]. J Cell Mol Med,2011,15(3):635-646.
  • 9Atsuta I,Liu S,Miura Y,et al. Mesenehymal stem cells inhibit Multiple myeloma cells via the Fas/Fas ligand pathway [J]. Stem Cell Res Ther, 2013,4(5):111.
  • 10Liu J,Han G,Liu H,et al. Suppression of eholangioearv- cinoma cell growth by human umbilical cord mesenchymal stem cells:a possible role of Wnt and Akt signaling [J]. PLoS One, 2013,8(4) : e62844.

二级参考文献12

  • 1Bonnet D, Diek J E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell[J]. Nat Med, 1997,3 : 730-737.
  • 2Al-Hajj M, Wieha M S, Benito-Hernandez A. et al. Prospective identification of tumorigenic breast cancer cells[J ]. Proc Acad Sci USA, 2003,100 : 3983-3988.
  • 3Singh S K, Clarke I D,Terasaki M, et al. Identification of a cancer stem cell in human brain tumors[J]. Cancer Res,2003, 63:5821-5828.
  • 4Fang D, Nguyen T K,Leishear K, et al. A tumorigenic subpopulation with stem cell properties in melanomas [J]. Cancer Res, 2005,65 : 9328-9337.
  • 5Matsueda S, Yao A, Ishihara Y, el al. A prostate stem cell antigen-derived peptide immunogenic in HLA-A24-prostate cancer patients[J]. Prostate, 2004, 60 : 205-213.
  • 6Calabrese P, Tavare S, Shibata D. Pretumor progression: clonal evolution of human stem cell populations [J]. Am J Pathol, 2004,164:1337-1346.
  • 7Passegue E, Jamieson C H M, Ailles L E,et al. Normal and leukemic hematopoiesis: Are leukemias a stem cell disorder or a reacquisition of stem cell characteristics[J]? PNAS, 2003, 100: 11842-11849.
  • 8Li L, Neaves W B. Normal stem ceils and cancer stem cells: the niche matters [J]. Cancer Res, 2006, 66: 4553-4557.
  • 9Crowe D L, Parsa B, Sinha U K. Relationships between stem cells and cancer stem cells [J]. Histol Histopathol, 2004,19: 5905-5919.
  • 10Owens DM, Watt F M. Contribution of stem cells and differentiated cells to epidermal tumours [J]. Nat Rev Cancer, 2003,3:444-451.

共引文献1

同被引文献18

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部